NeurAxon Announces Presentations at the 2011 Biotechnology Information Institute International Convention and the World Drug Targets Summit
6/23/2011 8:25:58 AM
More...
|
NeurAxon Announces NXN-188 Phase 2 Data Demonstrating Efficacy in Acute Migraine
11/1/2010 10:39:06 AM
More...
|
NeurAxon's NXN-188 Named One of 10 Most Promising Neuroscience Projects by Windhover Information Inc.
10/26/2010 10:48:19 AM
More...
|
NeurAxon Named One of Canada's Top 10(TM) Life Science Companies
10/14/2010 8:17:24 AM
More...
|
NeurAxon Announces Closing of Convertible Debenture Financing
9/29/2010 10:10:53 AM
More...
|
NeurAxon to Present at Upcoming Investor and Business Development Conferences
9/28/2010 10:41:21 AM
More...
|
NeurAxon to Present at BMO Capital Markets 10th Annual Focus on Healthcare Conference August 5, 2010
7/29/2010 8:55:53 AM
More...
|
NeurAxon to Present at 9th Annual Needham Healthcare Conference June 9, 2010
6/2/2010 9:51:44 AM
More...
|
NeurAxon to Make Multiple Presentations at the International Symposium on Nitric Oxide and Other Gaseous Neurotransmitters
5/18/2010 1:38:56 PM
More...
|
NeurAxon Awarded Grant from The Michael J. Fox Foundation to Research Novel Treatment Approach for Parkinson's Disease
1/11/2010 10:11:44 AM
More...
|
|